Equity
Insmed Incorporated (INSM) perpetual futures
INSM perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade INSMUSDT.
Insmed Incorporated is a biopharmaceutical company developing treatments for severe and rare conditions, including ARIKAYCE for adult MAC lung disease and pipeline candidates Brensocatib and Treprostinil Palmitil Inhalation Powder.
Price chart
Interactive TradingView chart
TradingView symbol NASDAQ:INSM
Loads TradingView's third-party widget (about 1 MB) on demand.
Trading data
Perpetual market activity
1/1 live markets
Trading data
Perpetual market activity
Spot performance
MEXCTradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kThin liquidity · 1 of 1 venues absorb $10k · Typical cost: +27.9 bps
Cheapest execution: MEXC · +27.9 bps
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
INSMTightest spread
INSMHighest volume
INSMFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketCompany data
Company fundamentals
Updated 41m ago
Company data
Company fundamentals
More metrics
Fundamental detail
Annual + quarterlyRefreshed 41m ago
Charts: revenue, profit, cash flow & valuation
Next catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
INSM-PERPFilings
PendingTranscripts
PendingCompany news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Analyst track record
How the analysts covering INSM have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 213 | 510 |
| Analysts | 31 | 39 |
| Buy / hold / sell | 205 / 8 / 0 | 497 / 13 / 0 |
| Upgrades / downgrades / initiations | 1 / 1 / 9 | 1 / 2 / 20 |
| Price targets hit / missed | 0 / 197 (0%) | 201 / 259 (44%) |
| Avg. return after a rating (TipRanks) | -44.6% | +4.3% |
| Best / worst call | -21.4% / -58.0% | +222.9% / -58.0% |
After buy calls on this stock: median 21-day move +1.4% vs S&P 500 +1.0% (n = 479)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Jason ZemanskyBank of America Securities100% hit rate on this stock · 30 targets measuredBuytarget $207Oct 12, 2026
- Graig SuvannavejhMizuho Securities100% hit rate on this stock · 24 targets measuredBuytarget $154Oct 29, 2026
- Ritu BaralTD Cowen100% hit rate on this stock · 22 targets measuredBuytarget $243Aug 6, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Oct 30, 2026 | Conor MacKayBMO Capital | BuyMaintained | $192 | article ↗ |
| Oct 30, 2026 | Ashwani VermaUBS | BuyMaintained | $172 | article ↗ |
| Oct 29, 2026 | Leonid TimashevRBC Capital | BuyMaintained | $195 | article ↗ |
| Oct 30, 2026 | Maxwell SkorMorgan Stanley | BuyMaintained | $213 | |
| Oct 30, 2026 | Andrea NewkirkGoldman Sachs | BuyMaintained | $194 |
TipRanks data via FMP · computed Oct 30, 2026 · 213 ratings
Frequently asked questions
Where can I trade INSM perpetual futures?
Insmed Incorporated (INSM) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade INSM around the clock?
Yes. Unlike the underlying stock, INSM perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on INSM perpetuals?
Right now the INSM perp funding rate is -12.5% annualized (venue median), ranging from -12.5% to -12.5% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the INSM perp price compare to the Insmed Incorporated stock?
The venue-median INSM perp mark is $113.3 versus a reference stock price of $113.3, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a INSM perpetual future?
A INSM perpetual is a derivative that tracks the price of Insmed Incorporated with no expiry date. It lets you take long or short exposure to Insmed Incorporated on crypto venues, around the clock.
What is INSMUSDT perpetual?
INSMUSDT is the symbol most crypto exchanges use for the Insmed Incorporated perpetual settled in USDT (Tether). It tracks the INSM share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/insm-perp"><img src="https://perpequities.com/badge/insm-perp.svg" width="240" height="64" alt="INSM perpetuals · perpequities.com" loading="lazy"></a>